⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4155167 | 1.00 | — | — | |
| SCHEMBL11264582 | 0.71 | — | — | |
| SCHEMBL43592 | 0.71 | — | — | |
| SCHEMBL43591 | 0.71 | — | — | |
| SCHEMBL4157492 | 0.69 | — | — | |
| SCHEMBL134444 | 0.67 | — | — | |
| SCHEMBL9702995 | 0.65 | — | — | |
| SCHEMBL8110529 | 0.64 | — | — | |
| SCHEMBL1541765 | 0.64 | — | — | |
| SCHEMBL5691105 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090105292-A9 | Glucocorticoid Receptor Modulator Compounds and Methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2009-04-23 | — | — | US | claimed |
| US-20070281959-A1 | Glucocorticoid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2007-12-06 | — | — | US | claimed |
| EP-1718653-A1 | GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY | Ligand Pharmaceuticals Inc. (US) | 2006-11-08 | — | — | EP | claimed |
| WO-2005082909-A1 | GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2005-09-09 | — | — | WO | claimed |
| US-20090105292-A9 | Glucocorticoid Receptor Modulator Compounds and Methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2009-04-23 | — | — | US | disclosed |
| US-20070281959-A1 | Glucocorticoid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2007-12-06 | — | — | US | disclosed |
| EP-1718653-A1 | GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY | Ligand Pharmaceuticals Inc. (US) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005082909-A1 | GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2005-09-09 | — | — | WO | disclosed |
| EP-0793140-B1 | Processing composition for silver halide photographic light-sensitive material, developer and processing method using the same | FUJI PHOTO FILM CO LTD (JP) | 2000-08-09 | — | — | EP | disclosed |
| US-5994040-A | USING A HYDROXYANILINE COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1999-11-30 | — | — | US | disclosed |
| US-5821040-A | PROCESSING MATERIAL WITH HYDROQUINONE-FREE DEVELOPING SOLUTION COMPRISING ASCORBIC ACID DERIVATIVE AND DITHIOTHIADIAZOLE DERIVATIVE | FUJI PHOTO FILM CO., LTD. (JP) | 1998-10-13 | — | — | US | disclosed |
| EP-0793140-A1 | Processing composition for silver halide photographic light-sensitive material, developer and processing method using the same | FUJI PHOTO FILM CO., LTD. (JP) | 1997-09-03 | — | — | EP | disclosed |
| US-5578433-A | DIHYDROXYFURANONE DEVELOPER | FUJI PHOTO FILM CO., LTD. (JP) | 1996-11-26 | — | — | US | disclosed |
| EP-0733364-A1 | MEDICINAL COMPOSITION FOR CIRCULATORY ORGAN | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1996-09-25 | — | — | EP | disclosed |